Hemostatic phenotype of thrombi derived from STEMI patients on cardiovascular prevention therapy

Hemostatic phenotype of thrombi derived from STEMI patients on cardiovascular prevention therapy

Introduction: Aspirin and statin therapy are the basis of cardiovascular disease (CVD) prevention therapy. Recent data have suggested new additional preventive mechanisms: both aspirin and statin exhibit anti-inflammatory effects within intracoronary thrombi. As inflammation, aggregation, and thromb...

Full description

Bibliographic Details
Main Authors: Jeske J. K van Diemen, Bernard J Smilde, Wessel W Fuijkschot, P Stefan Biesbroek, Yolande E Appelman, Paul A. J Krijnen, Yvo M Smulders, Hans W. M Niessen, Abel Thijs
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of the Practice of Cardiovascular Sciences
Subjects:
aspirin therapy
coagulation
coronary thrombi
fibrinolysis
statin therapy
Online Access:http://www.j-pcs.org/article.asp?issn=2395-5414;year=2019;volume=5;issue=2;spage=86;epage=90;aulast=van

Internet

http://www.j-pcs.org/article.asp?issn=2395-5414;year=2019;volume=5;issue=2;spage=86;epage=90;aulast=van

Similar Items